These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6803030)

  • 1. [Recent findings on ristocetin in the field of biochemistry].
    Nakamura H; Abe T
    Nihon Rinsho; 1981; 39(12):3643-6. PubMed ID: 6803030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH conference. Factor VIII.
    Ann Intern Med; 1977 May; 86(5):598-616. PubMed ID: 300583
    [No Abstract]   [Full Text] [Related]  

  • 5. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man.
    Bensoussan D; Levy-Toledano S; Passa P; Caen J; Canivet J
    Diabete Metab; 1977 Dec; 3(4):223-7. PubMed ID: 304425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 11. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
    Ogata K; Minami S; Kamiya T
    Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
    [No Abstract]   [Full Text] [Related]  

  • 13. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human factor VIII and platelet membrane glycoproteins implicated in ristocetin-induced aggregation (author's transl)].
    Niiya K; Koya H; Hayashi H; Nozaki H; Kitajima K
    Rinsho Ketsueki; 1978 Oct; 19(10):1322-31. PubMed ID: 570230
    [No Abstract]   [Full Text] [Related]  

  • 15. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Relationship between factor VIII and von Willebrand's factor in plasma and serum.
    Koutts J; Gude N; Firkin B
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081756
    [No Abstract]   [Full Text] [Related]  

  • 19. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.